AI-generated summary
The authors report a systematic review and meta-analysis of 17 randomized trials (835 participants) on red or near-infrared photobiomodulation for tendinopathy. Pain and function were compared with sham or other treatments, with and without exercise. The authors describe the evidence quality as very low to moderate and conclude there is very-low-to-moderate quality evidence that photobiomodulation has utility as a standalone or adjunctive therapy.
- Participants
- 835
- Studies included
- 17
- Who or what was studied
- Adults with tendinopathy disorders enrolled in randomized controlled trials
- Limits stated in the abstract
- The authors state that evidence quality ranged from very low to moderate according to GRADE, and that high quality evidence supporting its use is lacking.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
Background
Tendinopathy is a common clinical condition that can significantly affect a person's physical function and quality of life. Despite exercise therapy being the mainstay of tendinopathy management, there are many potential adjunct therapies that remain under investigated, one of which is photobiomodulation (PBM). PBM uses varied wavelengths of light to create a biological effect. While PBM is used frequently in the management of tendinopathy, high quality evidence supporting its utility is lacking.
Methods
A systematic search of the Pubmed, CINAHL, SCOPUS, Cochrane Database, Web of Science and SPORTSDICUS databases was performed for eligible articles in August 2020. Randomized Control Trials that used red or near-infrared PBM to treat tendinopathy disorders that made comparisons with a sham or 'other' intervention were included. Pain and function data were extracted from the included studies. The data were synthesized using a random effects model. The meta-analysis was performed using the mean difference (MD) and standardized mean difference (SMD) statistics.
Results
A total of 17 trials were included (n = 835). When compared solely to other interventions PBM resulted in similar decreases in pain (MD -0.09; 95% CI - 0.79 to 0.61) and a smaller improvement in function (SMD -0.52; 95% CI - 0.81 to - 0.23). When PBM plus exercise was compared to sham treatment plus exercise, PBM demonstrated greater decreases in pain (MD 1.06; 95% CI 0.57 to 1.55) and improved function (MD 5.65; 95% CI 0.25 to 11.04). When PBM plus exercise was compared to other interventions plus exercise, no differences were noted in pain levels (MD 0.31; 95% CI - 0.07 to 0.70). Most studies were judged as low-risk of bias. The outcome measures were classified as very low to moderate evidence quality according to the Grading of Recommendation, Development and Evaluation tool.
Conclusion
There is very-low-to-moderate quality evidence demonstrating that PBM has utility as a standalone and/or adjunctive therapy for tendinopathy disorders.
Trial Registration
PROPERO
Registration Number
CRD42020202508 .
Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Tendinopathy, Meta-analysis, Near-infrared, Systematic review, Sham, Trial registration, Risk of bias. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.